Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasatinib + Chemotherapy in Ph+ ALL
NCT01724879Phase 2Completed
- Sponsor
- Goethe University Frankfurt
- Start
- Nov 2011
- Primary completion
- Sep 2015
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dasatinib in Acute lymphoblastic leukemia, Philadelphia chromosome positive, sponsored by Goethe University Frankfurt. Started Nov 2011; status: completed.
02
Drugs
dasatinib
03
Conditions
Acute lymphoblastic leukemia, Philadelphia chromosome positive
Beyond the preview
Go deeper on NCT01724879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01724879.